Literature DB >> 11147677

Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis.

P Bornstein1, T R Kyriakides, Z Yang, L C Armstrong, D E Birk.   

Abstract

Thrombospondin 2 (TSP2)-null mice, generated by targeted disruption of the Thbs2 gene, display a complex phenotype that is characterized, in part, by a variety of connective tissue abnormalities and increased vascular density in skin and subcutaneous tissues. In this paper we summarize the evidence that TSP2 functions as a matricellular protein to influence cell function by modulating cell-matrix interactions, rather than acting as an integral component of the matrix. Thus, the structurally abnormal collagen fibrils detected in skin appear to be the consequence of the defective adhesion demonstrated by dermal fibroblasts in culture that, in turn, result from increased matrix metalloproteinase 2 (MMP2, gelatinase A) production by these cells. Corroborating evidence for such a mode of action comes from transmission electron microscopic images of developing flexor muscle tendons that show distinct abnormalities in fibroblast-collagen fibril interactions in TSP2-null tissue. The increased vascular density seen in skin of TSP2-null mice can be reproduced in a number of models of injury, including subcutaneous implantation of polyvinyl alcohol sponges and silicone rubber discs, and excisional skin wounds. Experiments are proposed to distinguish between a primarily endothelial cell versus an extracellular matrix origin for the increased angiogenesis in TSP2-null mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11147677     DOI: 10.1046/j.1087-0024.2000.00005.x

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  47 in total

1.  Thrombospondin-2 deficiency in growing mice alters bone collagen ultrastructure and leads to a brittle bone phenotype.

Authors:  Eugene Manley; Joseph E Perosky; Basma M Khoury; Anita B Reddy; Kenneth M Kozloff; Andrea I Alford
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

2.  ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2.

Authors:  Nathan V Lee; Makoto Sato; Douglas S Annis; Joseph A Loo; Lily Wu; Deane F Mosher; M Luisa Iruela-Arispe
Journal:  EMBO J       Date:  2006-11-02       Impact factor: 11.598

3.  Functional role of periostin in development and wound repair: implications for connective tissue disease.

Authors:  Douglas W Hamilton
Journal:  J Cell Commun Signal       Date:  2008-07-20       Impact factor: 5.782

Review 4.  Matricellular proteins and biomaterials.

Authors:  Aaron H Morris; Themis R Kyriakides
Journal:  Matrix Biol       Date:  2014-03-20       Impact factor: 11.583

5.  Correlation of perfusion parameters with genes related to angiogenesis regulation in glioblastoma: a feasibility study.

Authors:  R Jain; L Poisson; J Narang; L Scarpace; M L Rosenblum; S Rempel; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

Review 6.  Thrombospondin-4 in tissue remodeling.

Authors:  Olga Stenina-Adognravi; Edward F Plow
Journal:  Matrix Biol       Date:  2017-11-11       Impact factor: 11.583

Review 7.  Thrombospondin-2 and extracellular matrix assembly.

Authors:  Nicole E Calabro; Nina J Kristofik; Themis R Kyriakides
Journal:  Biochim Biophys Acta       Date:  2014-01-15

8.  Molecular dysexpression in gastric cancer revealed by integrated analysis of transcriptome data.

Authors:  Xiaomei Li; Weiwei Dong; Xueling Qu; Huixia Zhao; Shuo Wang; Yixin Hao; Qiuwen Li; Jianhua Zhu; Min Ye; Wenhua Xiao
Journal:  Oncol Lett       Date:  2017-03-03       Impact factor: 2.967

9.  Secreted protein acidic and rich in cysteine (SPARC)-null mice exhibit more uniform outflow.

Authors:  Swarup S Swaminathan; Dong-Jin Oh; Min Hyung Kang; Ruiyi Ren; Rui Jin; Haiyan Gong; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-21       Impact factor: 4.799

10.  Molecular control of vascular development by the matricellular proteins CCN1 (Cyr61) and CCN2 (CTGF).

Authors:  Brahim Chaqour
Journal:  Trends Dev Biol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.